Protein arginine methyltransferase 6 suppresses adipogenic differentiation by repressing peroxisome proliferator-activated receptor activity

被引:13
作者
Hwang, Jee Won [1 ]
So, Yun-Seong [1 ]
Bae, Gyu-Un [1 ]
Kim, Su-Nam [2 ]
Kim, Yong Kee [1 ]
机构
[1] Sookmyung Womens Univ, Coll Pharm, Res Inst Pharmaceut Sci, 100 Cheongpa Ro 47 Gil, Seoul 140742, South Korea
[2] Korea Inst Sci & Technol, Gangneung Inst, Nat Prod Res Ctr, Kangnung 210340, South Korea
基金
新加坡国家研究基金会;
关键词
protein arginine methyltransferase 6; peroxisome proliferator-activated receptor; adipogenic differentiation; epigenetics; arginine 2 on histone H3 asymmetric di-methylation; PPAR-GAMMA; TISSUE DISTRIBUTION; METHYLATION; THIAZOLIDINEDIONES; EXPRESSION; PRMT6; GENE; AGONISTS; ALPHA; ACID;
D O I
10.3892/ijmm.2019.4147
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The present study demonstrated that protein arginine methyltransferase 6 (PRMT6) negatively regulates the activity of peroxisome proliferator-activated receptor (PPAR). The results indicated that the overexpression of PRMT6 inhibited the transactivity of PPAR and subsequently decreased the expression levels of PPAR target genes. Contrarily, the depletion or inhibition of PRMT6 increased PPAR reporter activity and the expression of its target genes. It was also confirmed that PRMT6 was involved in the process of adipocyte differentiation. In addition, PRMT6 interacted with, but did not methylate, PPAR. PRMT6 bound to the PPAR-responsive regulatory element of the adipocyte Protein 2 (aP2) promoter in conjunction with PPAR and generated the repressive epigenetic mark arginine 2 on histone H3 asymmetric di-methylation, which suppressed aP2 gene expression. Therefore, PRMT6 may serve as an important regulator of PPAR activity in adipogenic differentiation and may be an attractive therapeutic target for human metabolic diseases.
引用
收藏
页码:2462 / 2470
页数:9
相关论文
共 41 条
  • [1] PPARγ signaling and metabolism: the good, the bad and the future
    Ahmadian, Maryam
    Suh, Jae Myoung
    Hah, Nasun
    Liddle, Christopher
    Atkins, Annette R.
    Downes, Michael
    Evans, Ronald M.
    [J]. NATURE MEDICINE, 2013, 19 (05) : 557 - 566
  • [2] Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans - No alteration in adipose tissue of obese and NIDDM patients
    Auboeuf, D
    Rieusset, J
    Fajas, L
    Vallier, P
    Frering, V
    Riou, JP
    Staels, P
    Auwerx, J
    Laville, M
    Vidal, H
    [J]. DIABETES, 1997, 46 (08) : 1319 - 1327
  • [3] Arginine methylation at a glance
    Bedford, Mark T.
    [J]. JOURNAL OF CELL SCIENCE, 2007, 120 (24) : 4243 - 4246
  • [4] Protein Arginine Methylation in Mammals: Who, What, and Why
    Bedford, Mark T.
    Clarke, Steven G.
    [J]. MOLECULAR CELL, 2009, 33 (01) : 1 - 13
  • [5] Implications of the endogenous PPAR-gamma ligand, 15-deoxy-delta-12, 14-prostaglandin J2, in diabetic retinopathy
    Behl, Tapan
    Kaur, Ishneet
    Goel, Heena
    Kotwani, Anita
    [J]. LIFE SCIENCES, 2016, 153 : 93 - 99
  • [6] The mechanisms of action of PPARs
    Berger, J
    Moller, DE
    [J]. ANNUAL REVIEW OF MEDICINE, 2002, 53 : 409 - 435
  • [7] PPAR-γ Agonists and Their Role in Type 2 Diabetes Mellitus Management
    Bermudez, Valmore
    Finol, Freddy
    Parra, Nailyn
    Parra, Maria
    Perez, Adriana
    Penaranda, Lianny
    Vilchez, Daviel
    Rojas, Joselyn
    Arraiz, Nailet
    Velasco, Manuel
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2010, 17 (03) : 274 - 283
  • [8] Arginine Methylation: The Coming of Age
    Blanc, Romeo S.
    Richard, Stephane
    [J]. MOLECULAR CELL, 2017, 65 (01) : 8 - 24
  • [9] Blanquicett Carmelo, 2008, Cancer Ther, V6, P25
  • [10] Methylation of tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression
    Boulanger, MC
    Liang, C
    Russell, RS
    Lin, RT
    Bedford, MT
    Wainberg, MA
    Richard, S
    [J]. JOURNAL OF VIROLOGY, 2005, 79 (01) : 124 - 131